Suggestions
Eddie Martucci
Co-Founder and CEO at Akili Interactive Labs; VP at PureTech Ventures
Eddie Martucci, Ph.D., is a life sciences entrepreneur and the co-founder of Akili Interactive Labs, Inc., a pioneer in digital therapeutics. He co-founded Akili in 2011 with the vision of transforming cognitive medicine through innovative technology. Under his leadership, Akili developed EndeavorRx, the first FDA-approved video game-based treatment for ADHD, marking a significant milestone in digital medicine.124
Martucci served as Akili's CEO until October 2023, when he transitioned to the role of Chair of the Board. During his tenure, he guided the company through key milestones, including its public listing and a strategic pivot from a prescription-based to a non-prescription business model.12 He also co-founded other health-focused startups under PureTech Health and contributed to launching its digital health initiatives.23
Academically, Martucci holds a B.S. in Biochemistry from Providence College and an M.Phil. and Ph.D. from Yale University, where he specialized in pharmacology and molecular biophysics.23 He is also a founding board member of the Digital Therapeutics Alliance and frequently participates in discussions on healthcare innovation.2
Highlights
Extremely excited to share that Akili has received FDA authorization for EndeavorOTC, a digital treatment for adults with ADHD. This marks another first for Akili, as EndeavorOTC is the first digital over-the-counter treatment, now on-label. So cool.
Over-the-counter is an important evolution of the digital treatment landscape - as it means a product is both clinically validated AND available without a prescription. Treating your health condition with a product that is safe and low-friction to obtain, but that you can trust has real efficacy. Think Prilosec OTC, Claritin, etc. It’s rare to be able to bring a product like this to market, and I personally think it’s a much–needed model for patients in the growing digital treatment landscape (truly a fit for digital distribution - it’s just a few clicks away). For those who haven’t followed the whole story, we put this product on the market as part of the public health emergency, but this news marks the successful completion of the official FDA review process of efficacy and safety, and is a big digital “first.”
I’m proud of the entire Akili team that got it done - a long time in the making!
www.EndeavorOTC.com
https://lnkd.in/eYdszYRA
As many know, Akili re-structured our workforce last week to focus around our licensing work. And while an incredible core team remains to keep pushing the bounds of our platform, there are just as many incredible Akilians who are now actively searching for the next chapter in their careers. If you're looking for talent for your healthtech/digital health/biotech business and have any needs for hard-working, passionate people, please reach out and I can likely point a few your way!
